Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl Fumarate in Acute Ischemic Stroke
NCT04890353Phase 2Terminated
- Sponsor
- Xuanwu Hospital
- Start
- Dec 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dimethyl fumarate in ischemic stroke, sponsored by Xuanwu Hospital. Started Dec 2021; status: terminated.
02
Drugs
dimethyl fumarate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04890353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04890353.